ethyl 4-(4-cyanophenyl)-2-hydroxy-4-oxobut-2-enoate, 97%, 250mg

2-adamantanol, min. 98%, for synthesis, 50 g, glass packaging

Sodium bismuthate dihydrate, min. 99%, pa, 100 g, plastic packaging.

3-(Piperidin-4-yl)pyridine dihydrochloride, 98%, 500mg

2-Chloro-pyridine-3-yl-acetic acid, 97.0%, 25g

[2-(Methoxycarbonyl)thiophen-3-yl]boronic acid, 98%, 1g

3-Phenyl-isoxazole-5-carboxylic acid, 97.0%, 10g

(S)-Morpholine-3-carboxylic acid hydrochloride, 95.0%, 5g

Methyl 4-hydroxy-2,6-dimethylbenzoate, 95.0%, 1g

(Z)-dodec-8-en-1-yl acetate, 90%, 100mg

6-Fluoro-2-methyl-1,3-benzothiazole-5-carbaldehyde, 98%, 500mg

N-[(1S,2S)-2,3-Dihydro-2-[(2-methoxy-6-methylphenyl)thio]-1H-inden-1-yl]-1,1,1-trifluoromethanesulfonamide, 50mg

Trimethyl((2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethynyl)silane, 98%, 100mg